Peijia Medical Limited (HKG:9996)

Peijia Medical Revenue

Peijia Medical had revenue of 424.50M CNY in the half year ending June 30, 2026, with 40.94% growth. This brings the company's total for the last twelve months to 783.99M, up 17.42% year-over-year. In the year 2025, Peijia Medical had annual revenue of 712.87M with 15.82% growth. That makes Peijia Medical the 21,560th largest company in the world by revenue and 1,260th in Hong Kong.

• Revenue (ttm): 783.99M CNY
• Revenue Growth: +17.42%
• P/S Ratio: 3.08
• Revenue / Employee: 758.95K CNY
• Employees: 1,033
• Market Cap: 2.59B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

Chart

• Neurointerventional Business 422.78M 59.3%
• Transcatheter Valve Therapeutic Business 290.09M 40.7%

Fiscal year ended Dec 31, 2025 See the full Peijia Medical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	712.87M	97.39M	15.82%
Dec 31, 2024	615.48M	174.36M	39.53%
Dec 31, 2023	441.13M	190.29M	75.86%
Dec 31, 2022	250.83M	114.30M	83.71%
Dec 31, 2021	136.53M	97.88M	253.21%

Data Source: S&P Global Market Intelligence Last updated: Sep 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 21, 2026

Data Sources Report a data error